Onno van de Stolpe

From Wikipedia, the free encyclopedia

Onno van de Stolpe (born 25 October 1959, Geldrop[1]) is a Dutch businessman, he is currently the CEO of Galapagos Genomics.

[edit] Education

He obtained a MSc degree from the Agricultural University in Wageningen (the Netherlands).

[edit] Career

He started his career as Manager Business Development at MOGEN in Leiden. After this, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. He joined Molecular Probes in the USA and became Managing Director of Molecular Probes Europe, where he established the European headquarters. In 1998, he joined Introgene (now Crucell) and became Managing Director Genomics after which he founded Galapagos in 1999.

[edit] Source

• De Nederlandse durfal van Galapagos (Dutch)
• Galapagos sluit overeenkomst met Eli Lilly (Dutch)